| Product Code: ETC9517476 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import shipments of nucleic acid testing (NAT) instrumentation in 2024 were primarily sourced from the United States of America, China, Netherlands, Trinidad and Tobago, and Taiwan. Despite a high level of market concentration in 2023, the Herfindahl-Hirschman Index (HHI) remained at a high level in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was notably negative at -16.08%, with a significant decline in growth rate from 2023 to 2024 at -45.44%. This indicates a challenging market environment for NAT instrumentation imports in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Nucleic Acid Testing-NAT Instrumentation Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market - Industry Life Cycle |
3.4 Suriname Nucleic Acid Testing-NAT Instrumentation Market - Porter's Five Forces |
3.5 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Suriname Nucleic Acid Testing-NAT Instrumentation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for accurate and rapid diagnostic testing in Suriname |
4.2.2 Growing awareness about the importance of early disease detection and management |
4.2.3 Technological advancements in nucleic acid testing instruments leading to improved efficiency and accuracy |
4.3 Market Restraints |
4.3.1 High initial investment costs associated with acquiring and maintaining NAT instrumentation |
4.3.2 Limited healthcare infrastructure and resources in Suriname |
4.3.3 Stringent regulatory requirements and compliance standards for NAT instrumentation |
5 Suriname Nucleic Acid Testing-NAT Instrumentation Market Trends |
6 Suriname Nucleic Acid Testing-NAT Instrumentation Market, By Types |
6.1 Suriname Nucleic Acid Testing-NAT Instrumentation Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.4 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Ligase Chain Reaction (LCR), 2021- 2031F |
6.1.5 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Transcriptionmediated Amplification (TMA), 2021- 2031F |
6.1.6 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Whole Genome Sequencing and Others, 2021- 2031F |
6.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Disease Diagnosis, 2021- 2031F |
6.2.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Forensic Testing, 2021- 2031F |
6.2.4 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.2.5 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Speciality Clinics, 2021- 2031F |
6.3.4 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Diagnostic Centres, 2021- 2031F |
6.3.5 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.3.6 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Nucleic Acid Testing-NAT Instrumentation Market Import-Export Trade Statistics |
7.1 Suriname Nucleic Acid Testing-NAT Instrumentation Market Export to Major Countries |
7.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Imports from Major Countries |
8 Suriname Nucleic Acid Testing-NAT Instrumentation Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Rate of adoption of NAT instrumentation in Suriname healthcare facilities |
8.3 Number of research and development projects focused on enhancing NAT instrumentation technology |
9 Suriname Nucleic Acid Testing-NAT Instrumentation Market - Opportunity Assessment |
9.1 Suriname Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Suriname Nucleic Acid Testing-NAT Instrumentation Market - Competitive Landscape |
10.1 Suriname Nucleic Acid Testing-NAT Instrumentation Market Revenue Share, By Companies, 2024 |
10.2 Suriname Nucleic Acid Testing-NAT Instrumentation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here